U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H13NO
Molecular Weight 187.2377
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NAFOMINE

SMILES

CC1=CC=C2C=CC=CC2=C1CON

InChI

InChIKey=DSBSLDVRDBLLFL-UHFFFAOYSA-N
InChI=1S/C12H13NO/c1-9-6-7-10-4-2-3-5-11(10)12(9)8-14-13/h2-7H,8,13H2,1H3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: https://www.google.ch/patents/US6323236

Nafomine is the muscle relaxant. It was tested on lower extremity spasms in spinal cord injuries.

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Not Provided
504
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Effects of nafomine malate on lower extremity spasms in spinal cord injuries (a preliminary study).
1971
Patents

Patents

5180831
2
5726314
2
US5180831
2
US6323236 B2
2

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
NAFOMINE
INN  
INN  
Official Name English
nafomine [INN]
Common Name English
O-((2-METHYL-1-NAPHTHYL)METHYL)HYDROXYLAMINE
Systematic Name English
Code System Code Type Description
FDA UNII
26C7FUA5S7
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
NCI_THESAURUS
C166545
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
EPA CompTox
DTXSID40866122
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
CAS
46263-35-8
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
PUBCHEM
31749
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
EVMPD
SUB09125MIG
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
SMS_ID
100000084435
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
INN
2860
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
ChEMBL
CHEMBL2110690
Created by admin on Sat Dec 16 15:47:30 GMT 2023 , Edited by admin on Sat Dec 16 15:47:30 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of NAFOMINE
SALT/SOLVATE (PARENT)
Structure of NAFOMINE MALATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966